Indicated to prevent passive, transient rabies infection after exposure to a rabid animal (dogs, mongoose, jackals, foxes).
Formulated from blood plasma from screened donors.
Uses:
Prevention of rabies infection post-exposure to a rabid animal.
Therapeutic Effects:
Provides immediate, passive immunity to the rabies virus by neutralizing the virus before it can infect the body's cells and cause disease.
Usually given along with the rabies vaccine to help the body develop its own antibodies against the virus.
Interaction with Other Drugs:
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Berirab P 300IU Injection, reducing effectiveness by causing undesirable side effects.
Storage:
Store in a refrigerator between 2°C to 8°C (36°F to 46°F).
Keep away from moisture, heat, and light.
Do not freeze.
Keep it in its original packaging until it is ready to be used.
Keep out of the reach of children and pets.
Administration:
Administered as an injection, usually by a healthcare professional.
Typically given into the muscle or at the site of the bite wound.
Safety Advice:
Pregnant women should consult their healthcare provider about their pregnancy status before receiving Berirab P 300IU Injection.
Breastfeeding women should consult a healthcare provider before taking the injection.
Individuals with lung conditions such as asthma or chronic obstructive pulmonary disease (COPD) may experience shortness of breath or worsened respiratory symptoms.
Patients with preexisting liver disease should talk to their healthcare provider before taking it.
Individuals should avoid consuming alcohol before or immediately after receiving Berirab P 300IU Injection.
Patients should monitor their response to the medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
Side Effects:
Serious: severe allergic reactions, respiratory distress, blood pressure changes, seizures or convulsions, chest pain, unusual warmth of limb.
Common: pain, swelling, or redness at the injection site, fever, headache, nausea, dizziness.
FAQs:
Can Berirab P 300IU Injection prevent rabies infection?
Berirab P 300IU Injection is not a vaccine and cannot prevent rabies infection. It is used to provide immediate passive immunity to individuals exposed to rabies who may not yet have developed their immune response. A rabies vaccine is typically given with Berirab P 300IU Injection to provide long-term protection against rabies.
Can Berirab P 300IU Injection be given to individuals with compromised immune systems?
Berirab P 300IU Injection can be given to individuals with compromised immune systems who have been exposed to rabies. However, it is important to consult with a healthcare provider before receiving this medicine, as these individuals may be at a higher risk of developing adverse reactions.
Can Berirab P 300IU Injection be given to individuals who have already received a rabies vaccine?
Berirab P 300IU Injection may be given to individuals who have already received a rabies vaccine as a part of post-exposure prophylaxis. However, the timing of the vaccine and Berirab P 300IU Injection administration may differ depending on the individual's vaccination history and the severity of the exposure.
Can Berirab P 300IU Injection be given to individuals who have received blood transfusions or blood products?
Berirab P 300IU Injection may interfere with the immune response to live virus vaccines, including measles, mumps, rubella, and varicella. Therefore, individuals who have received blood transfusions or products should consult with a healthcare provider before receiving this injection to determine the appropriate timing of any live virus vaccines.
Can Berirab P 300IU Injection be given to individuals with a history of Guillain-Barré syndrome?
Berirab P 300IU Injection may be associated with some individuals' increased risk of Guillain-Barré syndrome. Therefore, individuals with a history of Guillain-Barré syndrome should consult a healthcare provider before receiving this injection.
How long does the protective effect of Berirab P 300IU Injection last?
The protective effect of Berirab P 300IU Injection varies depending on the individual's immune response and the severity of the rabies exposure. It provides immediate passive immunity, but the duration of protection is limited. A rabies vaccine is typically given with this injection to provide long-term protection against rabies.
